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We describe an extension of Risch’s [(1990a,b) Am J Hum Genet 46:222-228, 
229-2411 method of linkage detection and exclusion for complex genetic traits. 
The method uses interval mapping to infer disease locus identity-by-descent (IBD) 
sharing for affected sib pairs (ASPs) based on marker information for the ASP 
and other genotyped family members. The method is likelihood based, and makes 
use of Risch’s parameterization in terms of recurrence risk ratios for relatives. We 
describe specific linkage detection and exclusion tests for use as genome screening 
tools to prioritize genomic regions for further study. We also examine issues of 
optimal study design. 
We advocate initially typing a large panel of ASPs (and no additional family 
members) with a map of genetic markers evenly spaced at 10-20-cM intervals. 
We recommend a screening procedure that 1) investigates further all regions with 
maximum lod scores greater than 1 and 2) excludes from consideration those regions 
that result in lod scores less than -2 at the smallest genetic effect that is viewed as 
important to detect. Further investigation of an interval might include typing other 
available families or family members, typing additional markers in the interval, 
and carrying out further statistical analyses. This strategy is efficient in the number 
of genotypings required and focuses attention on regions most likely to harbor a 
disease gene with a substantial impact on disease risk, while resulting in the pursuit 
of a manageable number of false-positive linkage results. Modification may be 
required if insufficient ASPs are available or if families come from a significantly 
admixed population. 0 1996 Wiley-Liss, Inc. 
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I NTRO DU CTlO N 
There have been many recent successes in the mapping and positional cloning of 
human disease genes. However, most such successes have involved simple Mendelian 
diseases with clear modes of inheritance. In contrast, many diseases exhibit familial 
aggregation but fail to exhibit any simple Mendelian mode of inheritance. Such com- 
plex genetic diseases include most of the diseases that have a substantial impact on 
the public health, including heart disease, many forms of cancer, hypertension, di- 
abetes, and schizophrenia. Identification of the genes involved in complex genetic 
diseases would have substantial impact on our understanding of disease etiology and 
on the prevention of disease occurrence. Because complex diseases likely are due 
to interplay of multiple genetic and environmental factors, mapping and cloning the 
genes for complex diseases is likely to be very difficult. However, recent successes 
such as the mapping of loci for insulin-dependent diabetes [Davies et al., 1994; Field 
et al., 1994; Hashimoto et al., 19941 and the identification of a rote for apolipoprotein 
E in Alzheimer disease [Strittmatter et al., 19931 provide a basis for optimism. 
The methods used in previous linkage studies fall into two general categories: 
mode-of-inheritance-based likelihood methods such as lod scores [Haldane and 
Smith, 1947; Morton, 19551 and location scores [Lathrop et al., 19841 and non- 
parametric mode-of inheritance-free methods such as sib pair [Penrose, 1935; Suarez 
et al., 19781 and affected-relative-pair [Weeks and Lange, 1988, 1992; Risch 1990b; 
Bishop and Williamson, 19901 methods. 
Mode-of-inheritance-based methods have the advantages of 1) being statistically 
efficient when the mode of inheritance is known, 2) providing an estimate of disease 
gene location, and 3) permitting both linkage detection and exclusion. The major 
problem in applying these methods to complex diseases is the choice of mode of 
inheritance. Performing linkage analysis using several different modes of inheritance 
is one solution; however, this approach can result in increased probability of falsely 
concluding linkage, or alternatively in a loss of power, and often the selection of 
genetic models can be rather ad hoc. 
Mode-of-inheritance-free methods are particularly suited to complex genetic 
diseases for which mode of inheritance generally is unknown. These methods use 
smaller subsets of family members, usually relative pairs, so that sampling family 
members generally is easier than when extended pedigrees are sought. Such meth- 
ods are computationally simple and easy to apply. However, traditional mode-of- 
inheritance-free methods generally have not been used to provide an estimate of 
disease gene location or to perform exclusion mapping, although in principle they 
could [Risch, 1990b, 19931. 
In this paper we extend Risch’s mode-of-inheritance-free method of linkage 
analysis parameterized by the recurrence risk ratios for first-degree relatives of 
an affected individual. This method is intermediate between the traditional mode- 
of-inheritance-based lod score method and non-parametric, mode-of inheritance- 
free relative pair methods. Like the traditional non-parametric methods, it does not 
require specification of the (unknown) mode of inheritance. Like standard mode- 
of-inheritance-based methods, it provides an estimate of disease gene location and 
permits both linkage mapping and exclusion. We employ a maximum likelihood 
interval mapping approach to test for linkage detection and exclusion and to esti- 
mate model parameters. Previous methods assumed knowledge of identity-by-descent 
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(IBD) status as might be determined given marker data on the affected sib pair (ASP) 
and their parents. In the context of these methods we examine the information gained 
by including parents or sibs (when parents are unavailable) in addition to the ASP. 
We evaluate power and efficiency of different constellations of family members, map 
densities, and marker informativities and evaluate critical values for linkage detection 
and exclusion. Finally, we propose a general strategy for mapping genes for complex 
genetic traits. 
We find that when a large number of ASPs are easy to obtain, an efficient study 
design for linkage detection is to type only the ASPs and no other family mem- 
bers for relatively widely spaced markers, say 10-20 cM. We recommend a genome 
screening procedure which investigates all intervals with lod scores greater than 1 by 
typing additional families and family members and additional markers in those inter- 
vals [see also Elston, 19921. Our simulations suggest that such a procedure results in 
an acceptably low false positive rate and exclusion of the majority of the intervals in 
which a disease locus is not present. Modification of this strategy may be required if 
insufficient ASPs are available, if families come from a significantly admixed pop- 
ulation, or if typing only the ASPs compromises accurate allele scoring. When the 
number of ASPs is limited, the information for linkage detection can be increased by 
typing additional family members of the ASPs. 
MATERIALS AND METHODS 
Model and Data 
The genetic disease model we use was first described by Risch [1990a,b]. The 
model is parameterized by the recurrence risk ratio AR that compares disease risk in 
a relative of type R of an affected individual to the disease risk of an individual cho- 
sen at random from the population, that is the population prevalence. For example, 
R might represent a sibling, offspring, grandchild, or cousin. For these different rel- 
ative classes, AR can be estimated in epidemiologic studies of the disease of interest. 
By parameterizing the model in terms of the recurrence risk ratio, specification of a 
more detailed mode-of-inheritance model can be avoided. Such an approach is inter- 
mediate between traditional relative pair techniques which include no genetic model 
parameters and standard likelihood-based methods that require full specification of 
the mode of inheritance. 
For a complex genetic disease, multiple loci may be involved in disease etiology. 
Each locus may be sufficient to cause disease, or the loci may show more complex 
interactions. Risch [ 1990al describes three such models of gene interaction. Here we 
assume that the marginal effect of at least one trait locus is detectable, separate from 
the other loci or environmental determinants with which it may interact, and let the 
parameter A: refer to the disease recurrence risk ratio to relative class R conferred 
by a specific susceptibility locus. For a single-locus Mendelian trait with no sporadic 
cases, AR = A:. In our investigations, we concentrate on the case when A: is of 
modest size, since for complex diseases this often will be the case. In the remainder 
of this paper we drop the distinction between AR and A:, with the understanding that 
in what follows the A’s refer to locus-specific recurrence risk ratios. 
In this paper we consider data on ASPs and additional members of the nuclear 
families of the ASPs, and so concentrate on A, and A,, the recurrence risk ratios to 
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siblings and offspring of affected individuals, respectively. Let zi be the probabili- 
ties that an ASP shares i genes identical by descent (IBD) at the disease locus. Risch 
[ 1987, 1990bl showed that for any disease locus the probabilities z = [ZO, z l ,  z2]  sat- 
isfy z = [0.25/A,, 0.50Ao/A,, 1 - 0.25/A, - 0.50Ao/A,]. Assuming a genetic model 
in which the alleles at the disease locus act additively, A, = A, = A ,  and z = [0.25/A, 
0.50,0.50 - 0.25/A]. When the specific locus is not related to the disease of inter- 
est, A, = A, = 1 and z = [1/4,1/2,1/4]. By typing genetic markers throughout the 
genome in ASPs and perhaps in additional family members, we seek to identify in- 
tervals in which the ASPs demonstrate elevated IBD sharing. For this purpose, we 
employ a likelihood-based interval-mapping approach for linkage mapping and exclu- 
sion mapping of complex diseases. For ease of explication, in much of what follows 
we assume an additive model, a map of codominant markers with known distances 
between the markers, and no genetic interference, although these assumptions are not 
all necessary (see Discussion). 
Test Statistics for Linkage Detection and Exclusion 
Consider the case of a disease locus flanked by two genetic markers (Fig. 1). 
Here we use only intervals defined by pairs of flanking markers, rather than a full 
multipoint analysis (but see Discussion). Let 0 be the recombination fraction between 
the flanking markers, and let and 02 be the recombination fractions between the 
disease locus and the first and second flanking markers, respectively. Assuming no 
interference, 0, = (0 - d1)/(l - 201). Let z = [z,, z1, z2] represent the true IBD shar- 
ing distribution at the disease locus in ASPs, and let X, be the marker phenotypes 
for all genotyped members of family n. To detect or exclude linkage, we calculate 
P(Xn I ASP; z, el ,  0), the probability of the marker data X, on family n conditional 
on the disease status of the ASP, since it is this disease information that brought the 
family to our attention. We defer calculation of this probability to the next section. 
Given N independent ASP families, we define the lod score as 
This lod score compares the likelihood of the data when there is a disease locus at 
a given location to the likelihood of the data when there is no disease locus in the 
interval [see Risch, 1990bl; it provides the basis to detect or to exclude linkage. 
To test for linkage in a particular interval we maximize the lod score over z 
and O1. We consider values in the range 0 5 O1 5 0 and z values in the “possible 
Fig. I. Definitions of interval mapping parameters: M I ,  M2,  genetic markers flanking the disease locus 
D; 8, 81, and 02, recombination fractions between the flanking markers and between the disease locus and 
marker loci; and d,  dl, and dZ, corresponding map distances. 
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triangle” representing models which are consistent with the effects of a single genetic 
locus on disease risk [Holmans, 19931. This triangle is bounded by the lines zo = 
0, z1 = 1/2, and z2 = 2zO. For an additive model zl = 1/2, and maximization is 
restricted to 0 5 20 I 1 /4 (or equivalently 1 /4 I 22 I 1 /2). For the additive model, 
we may parameterize in terms of A = 0.25/z0 and replace z = [1/4,1/2,1/4] by 
A = 1 .O. Large, positive lod scores suggest the presence of a disease locus. 
For exclusion mapping, we calculate the lod score as a function of 61 and z, or 
under additivity, 81 and A.  At a specific value of A ,  say AE, we exclude those parts 
of the interval which result in sufficiently negative lod scores and build an exclusion 
map of the genome, indicating those regions unlikely to contain a locus with marginal 
effect AE or greater [Risch, 19931. Alternatively, we could fix O1 or the portion of the 
interval of interest and then determine the A values which might be excluded. The 
same approaches can be taken for the more general model parameterized by z. 
At the null hypothesis value z = [1/4,1/2,1/4], the parameter space is degen- 
erate so that the recombination fraction between the disease locus and the flanking 
marker is not identifiable. As a result, when z = [1/4, 1/2, 1/41 the asymptotic dis- 
tribution of the likelihood ratio statistic is unknown (see Discussion). We use simu- 
lation to examine the empirical distribution of the maximum lod score. 
Likelihood 
To calculate the probability P(X I ASP; z, 6 , ,  6) of the marker data X for a family 
conditional on the disease status of the ASP, we condition on IBD sharing by the 
ASP at the disease and marker loci. Let ik, be 1 if the ASP shares an allele IBD 
from parent k = m(other) or f(ather) at locus j ,  and 0 otherwise. Here, j = 1, 2, or 
D for the first marker locus, second marker locus, and disease locus, respectively, 
Then ID = ( i , ~ ,  ip) and ZM = (i,, , im2, ifl, if2) completely describe the IBD sharing 
at the disease and marker loci, respectively. As an example, consider the families in 
Figure 2. In family 1 both parents are genotyped. At the first marker, the ASP share 
the father’s allele IBD but not the mother’s allele. At the second marker, both parents 
are homozygous and the IBD allele sharing status in the ASP is unknown. Thus IM E 
{(O,O, I ,  0), (0, 1, l,O), (O,O, 1 ,  l), (0,1, 1,l)). In family 2, if the unaffected sibling is 
not included, all 16 4-tuples indicating ASP IBD sharing are possible. Adding the 
genotype of the unaffected sibling allows the parental marker genotypes and ASP 
IBD status to be inferred unambiguously and IM = (1, 1, 1, 1). 
Conditioning on the IBD status of the ASP we can write the likelihood as 
where 
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family 1 family 2 
1 3  1 4  
1 1  1 1  
1 1  1 1  2 2  
1 1  1 1  2 2  
Fig. 2. Example of affected-sib-pair nuclear families. 
[Hauser et al., 19941. An analogous expression was obtained independently by Olson 
[ 1995al. 
The terms in the expression H(ZM; z, & , O )  are simple functions of the parame- 
ters. By definition 
if ID = (0,O) 
if 10 = (0, 1), (1,O). 
if I D  = ( 1 , l )  
P(ZD I ASP Z) = 
Under the assumptions of no inbreeding and no interference 
where 
H incorporates all of the information about the disease model and the position of the 
disease locus relative to the markers. In addition, H is trivial to calculate, and only 
24 = 16 terms are needed for each combination of z and 61. 
Calculation of P(X,ZM; 8)  is somewhat more complicated, but it is readily 
accomplished by using a variation of the Elston-Stewart [ 19711 algorithm; fur- 
ther, it needs to be carried out only once per family, independent of the num- 
ber of z and 6, values to be considered. We restrict our attention to the case of 
nuclear families, although generalization to extended pedigrees is possible. Let 
g = (g,,gf,gl,g2,. . . ,g.y) be a two-marker genotype vector for a family where m 
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is the function that results from peeling the s-2 non-ASP siblings onto the parents. 
P(gk) is the prior probability of genotype gk, and P(gi I gm,gf) is the (transmission) 
probability of offspring genotype gi given parental genotypes g, and gf.  Missing 
from (1) are the penetrance terms P(X I g). As described below, we carry out the 
summations only for those genotypes consistent with the observed marker pheno- 
types, so that the penetrance terms are all one and hence can be ignored. 
The last term in (1)  is the product of the conditional marker IBD probabilities 
given the genotypes of the ASP and a parent. Table I specifies these simple probabil- 
ities as a function of 8 and of parent genotypes and the identity-by-state (IBS) rela- 
tionship of the ASP alleles for each marker. Returning to example family 1 (Fig. 2), 
the father’s and mother’s contributions are described by lines 9 and 11 of the ta- 
ble, respectively. For family 2, ignoring the genotypes of the unaffected sibling, the 
marker genotypes of both parents are unknown; all parental genotypes gk consistent 
with the genotypes of the ASP must be considered, in this case lines 1, 5, 9, and 13. 
Taking into account the unaffected sibling reduces the number of possible parental 
genotypes to the case represented by line 13. 
To reduce computation, the parental genotype sum in (1) can be taken only over 
parental marker genotypes compatible with observed marker phenotypes; similarly 
the offspring sum can be taken over the intersection of the set of parental genotypes 
compatible with the set of observed offspring marker phenotypes. This strategy can 
substantially reduce the number of genotypes to be considered. At best, when parents 
and the ASP are genotyped, the set of compatible parental genotypes may include 
no more than four ordered two-marker-locus genotypes. At worst, when only the 
ASP is genotyped, given appropriate allele recoding, there are no more than 92 = 
8 1 possible ordered two-marker-locus genotypes and 8 l 2  = 6561 two-marker-locus 
mating types. 
Simulations 
We carried out computer simulations to examine power and size for linkage 
detection and exclusion, and the choice of critical values which might be used for 
a genome scan. For ease of explication, we focus on additive models for which 
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TABLE I. Conditional Identity-by-Descent (IBD) Probabilities for an Affected Sib Pair (ASP) at 
the Flanking Marker Loci Given Genotypes for One Parent and the ASP 
Parental genotype g k  ASP share 
homozygous at parent k allele IBS at Conditional marker IBD probabilitiesa 
Marker l?  Marker 2? Marker l ?  Marker 2? P(0,O) P(0 , l )  






















































"P(a, b)  = P(ikl = u, i k 2  = b I gl, g2, gk) where i k ,  is the indicator of ASP IBD allele sharing for parent k 
at marker j and g l ,  g2, and g k  are the two-locus genotypes for the ASP and parent k ;  11, = O2 + (1 - O)2; 
-, impossible case. 
A, = A, = h and z = [0.25/h, 0.50,0.50 - 0.25/h]. Since the locus-specific recur- 
rence risk ratios h for a complex disease often will be low, we consider hs of 1.0, 
1.2, 1.4, 1.6, 1.8, 2.0, and 3.0. For N = 100, 200,400, or 800 ASP families, we con- 
sider the information provided by genotyping the ASP together with N p  = 0, 1, or 
2 parents and N, = 0 to 6 additional sibs. We also consider the impact of distance 
between flanking markers (d = 2, 5 ,  10, 20 cM), marker informativity (two, four, or 
ten equally frequent alleles, heterozygosity = 0.50, 0.75, or 0.90), and disease locus 
position (in the middle of the interval and near a flanking marker). 
It has been noted by several investigators that errors in specification of allele fre- 
quencies and particularly population admixture can be serious problems in linkage 
studies, especially in affected-relative-pair studies [Weeks and Lange, 1992; Risch, 
1992; Freimer et al., 1993; Holmans, 19931. To address this issue, we simulated a 
sample of 400 ASPS from a mixture of two populations with different marker allele 
frequencies. For this simulation we used markers with eight alleles and allele fre- 
quencies 0.36, 0.13, 0.13, 0.13, 0.08, 0.08, 0.08, and 0.01 (heterozygosity = 0.80) 
in the first population, and with the frequencies either for the first two alleles or for 
the first and fifth alleles switched in the second population. A fraction a of the ASP 
families were chosen from the first population, the remaining fraction 1 - a from the 
second. To analyze these admixed data we assumed the averaged allele frequencies 
from the combined population. 
To simulate marker genotypes for the family members, we simulated genotypes 
first for the parents, next for the ASP conditional on the genotypes of the parents 
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and the parameters 81 and 13 and A ,  and finally for the additional siblings conditional 
on the genotypes of the parents and on 8. To facilitate comparisons of linkage in- 
formation provided by different family structures, we generated data for ten-person 
nuclear families but used marker genotypes from the subset of individuals of interest. 
This scheme allowed a more efficient comparison of different sampling strategies by 
reducing sampling variation. 
For each simulation condition we generated 1,000 replicate data sets. For each 
data set we calculated the maximum lod score and the maximum likelihood estimates 
of O1 and A.  In addition, for each of several values of A ,  we calculated the proportion 
of the interval excluded and noted whether the entire interval was excluded. 
R ES U LTS 
We begin by examining the expected maximum lod score and parameter esti- 
mates for different sample sizes, family structures, map densities, and marker het- 
erozygosities. Next we present size and power of tests for linkage detection and link- 
age exclusion based on the empirical distribution of the lod score. Finally we examine 
the impact of errors in the marker map on linkage detection. 
Effect of Typing Additional Family Members on the Maximum Lod Score 
Table I1 shows the expected maximum lod score for several values of the re- 
currence risk ratio for first degree relatives A .  Not surprisingly, as A increases, the 
expected maximum lod score increases so that disease loci with larger recurrence 
risk ratios are more easily detected than loci with smaller recurrence risk ratios. For 
a fixed number of families N, the most information for linkage is obtained when both 
parents are genotyped ( N p  = 2), the least when no parents are typed ( N p  = 0). How- 
TABLE 11. Expected Maximum Lod Score as a Function of the Number of Families N ,  the 
Number of Typed Parents N,,, and the Recurrence Risk Ratio h Given Markers With Four 
Equally-Frequent Alleles, a 10-cM Intermarker Distance, and Disease Locus in the Middle of the 
Interval* 
h 
N N" 1 .o 1.2 1.4 1.6 1.8 2.0 3 .O 
100 0 0.15 0.43 0.78 1.15 1.49 1.80 2.97 
1 0.16 0.47 0.84 1.26 1.65 1.99 3.31 
2 0.16 0.52 0.96 1.45 1.91 2.32 3.92 
200 0 0.15 0.6 1 1.26 1.98 2.65 3.25 5.57 
1 0.14 0.65 1.37 2.18 2.93 3.60 6.22 
2 0.15 0.75 1.58 2.52 3.42 4.24 7.44 
400 0 0.15 0.96 2.20 3.60 4.92 6.12 10.75 
1 0.15 I .05 2.42 4.01 5.49 6.84 12.10 
2 0.16 1.20 2.82 4.68 6.44 8.10 14.53 
800 0 0.13 1.59 4.01 6.80 9.38 11.83 21.18 
1 0.14 1.76 4.46 7.62 10.54 13.30 23.92 
2 0.15 2.04 5.22 8.97 12.46 15.82 28.75 
*Standard errors 5 ,0056JN. 
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ever, on a per genotype basis, typing only the ASP is the most efficient strategy [see 
also Risch, 1992; Holmans, 19931. The same number of genotypes are required when 
typing both parents and the ASP in N families as when typing just the ASP in 2N 
families, yet for the cases we considered, the expected maximum lod score was 17% 
to 46% larger when typing the 2N ASPs. Figure 3 shows the effect of typing siblings 
in addition to the ASP on the expected lod score for N = 400 nuclear families. Each 
additional sibling increases the expected maximum lod score, and typing six siblings 
in addition to the ASP provides almost as much information as typing both parents, 
but it is always better to type parents rather than siblings if the parents are avail- 
able. Again, on a per genotype basis, it is more efficient to type more ASPs rather 
than to type additional siblings. Since typing parents and/or additional siblings was 
seen to be less efficient than typing only ASPs, in subsequent analyses we restrict 
our attention to only ASPs. 
Effect of lntermarker Distance on the Maximum Lod Score 
Table I11 shows the expected maximum lod score when typing N = 100 or 400 
ASPs and no other family members. As expected, reducing the intermarker distance 
increases the expected maximum lod score; this increase is larger when the disease 
locus is in the middle of the interval than when it is near one of the markers. For ex- 




0 1 2 3 4 5 6 
Number of sibs genotyped in addition to the ASP 
* - 0 parents typed 0 0 0 1 parent typed - - - - - 2 parents typed 
Fig. 3. The increase in the expected maximum lod score given genotypes on additional siblings for 
N = 400 families typed with markers with four equally frequent alleles, d = 10 cM, and disease locus in 
the middle of the interval. 
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TABLE 111. Expected Maximum Lod Score and Means of the Maximum Likelihood Estimates 
of dl, the Distance Between the First Marker and the Disease Locus and a = 0.25/h, the 
Probability That the ASP Shares Zero Disease Genes IBD, When Typing N ASPs With Markers 
With Four Eauallv Freauent Alleles* 
N = 100 
Lod 
d(cM) h ZO 4 score 20 2, 
20 1 .o 
1.4 
2.0 
10 1 .o 
1.4 
2.0 
5 1 .0 
1.4 
2.0 











































































N = 400 
Lod 
score 20 2, 
0.17 0.236 - 
1.70 0.179 10.0 
2.19 0.172 3.3 
4.47 0.126 10.0 
6.21 0.1 17 1.9 
0.14 0.238 - 
2.20 0.177 4.8 
2.36 0.176 2.2 
6.12 0.125 4.9 
6.74 0.121 1.3 
0.13 0.240 - 
2.53 0.177 2.4 
2.56 0.177 1.6 
7.22 0.124 2.4 
7.36 0.123 1 .o 
0.12 0.241 - 
2.73 0.178 1 .o 
2.74 0.178 0.8 
8.00 0.124 1 .0 
8.01 0.124 0.7 
*Standard errors for the lod score 5 ,040 for N = 100 and 5 .081 for N = 400. Standard errors for io 5 
0.002 for N =I00 and 5 0.001 for N = 400. Standard errors for 21 5 0.30 for N = 100 and I 0.15 for 
N = 400. 
from 4.47 when the interval size d = 20 cM to 8.00 for d = 2 cM. However, this 
less than twofold increase in linkage information comes at the expense of a tenfold 
increase in genotyping effort. Thus, given sufficient ASPs, a plausible genome screen- 
ing strategy is to type markers at a relatively large intermarker distance, say d = 10 
or 20 cM, and then to type more markers in intervals with interesting maximum lod 
scores (see below). 
When the disease locus is close to one of the flanking markers, the expected 
maximum lod score is larger than when the disease locus is in the middle of the 
interval. For example, when N = 400, h = 2.0, and d = 20 cM, the expected maxi- 
mum lod score is 4.47 when the disease locus is in the middle of the interval and 6.21 
when the disease locus is near a flanking marker. This difference is larger for larger 
intervals since there is more opportunity for recombination between the disease locus 
and both markers when the disease locus is in the middle. 
Effect of Marker lnformativity on the Maximum Lod Score 
Table IV presents the expected maximum lod score for markers with two, four, or 
ten equally frequent alleles (heterozygosities 0.50,0.75, or 0.90, respectively) given a 
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TABLE IV. Effect of Marker Informativity on the Expected 
Maximum Lod Score for Markers With Two, Four, or Ten 
Equally Frequent Alleles Given N = 400 ASPs, A = 2.0, and 
d = 10 cM* 
Number of alleles at 










di ( W  
5 .O 0.1 
3.59 3.82 








*Standard errors 5 .087. 
10-cM map. As expected, as marker heterozygosity increases, the expected maximum 
lod score increases. This increase is the most striking when the disease locus is near 
a flanking marker. For example, when the number of alleles at the flanking marker 
closest to the disease locus increases from 4 to 10, the expected maximum lod score 
increases from 6.74 to 8.98. The increase in linkage information due to an increase 
in marker heterozygosity can be observed even at a distance. When the number of 
alleles at the marker further from the disease locus is increased from 4 to 10, the 
expected maximum lod score increases from 6.74 to 7.22. Linkage detection is clearly 
enhanced by choosing the most polymorphic markers. Even so, markers that are only 
modestly polymorphic still can provide substantial linkage information. 
Parameter Estimation 
Table 111 shows parameter estimates 90 and J1 for several intermarker distances 
d ,  recurrence risk ratios A = 0.25/zo, and disease locus positions d l .  In general, 
the parameters are reasonably well estimated. For 20, the bias is generally small and 
decreases with increasing number of ASPs N .  The bias in 90 is the greatest when 
zo = 0.25 (A = 1.0) since the estimation procedure forces zo I 0.25 (A 2 1.0); even 
in this case the bias is generally small, particularly when d is small and N is large. 
When the disease locus is in the middle of the interval, the bias in 2, is small 
and decreases as the interval size decreases. When the disease locus is near a flanking 
marker, the estimate of the disease locus position d l  is biased toward the center of the 
interval. Again, this is to be expected since by using information on flanking markers 
only, we do not allow the disease locus to be outside the interval. Results for more 
or less polymorphic markers are similar (data not shown). 
Size and Power to Detect Linkage 
Table V shows the empirical size and power of the linkage detection test when 
using a lod score of 1 ,  2, or 3 as the critical value for declaring suggestive evidence 
of linkage. Even at a relatively low lod score critical value of k = 1 ,  the probability 
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TABLE V. Probability of a Maximum Lod Score Greater Than k for N ASPs for Markers With 
Four Equally Frequent Alleles, a 10-cM Intermarker Distance, and Disease Locus in the Middle 
of the Interval 
A 
N k 1 .O 1.2 1.4 1.6 1.8 2.0 3.0 
100 1 0.024 0.13 0.30 0.48 0.61 0.71 0.93 
2 0.002 0.03 0.08 0.16 0.26 0.38 0.70 
3 0.000 0.00 0.02 0.05 0.09 0.15 0.45 
200 1 0.022 0.21 0.53 0.78 0.90 0.95 1 .oo 
2 0.003 0.05 0.20 0.44 0.63 0.77 0.98 
3 0.000 0.01 0.06 0.19 0.36 0.51 0.90 
400 1 0.025 0.38 0.81 0.97 1 .00 1 .oo 1 .oo 
2 0.003 0.13 0.49 0.8 1 0.96 0.99 1 .oo 
3 0.000 0.03 0.23 0.59 0.82 0.94 1 .oo 
800 1 0.020 0.65 0.98 1 .oo 1 .oo 1 .00 1 .oo 
2 0.002 0.30 0.89 1 .oo 1 .oo 1 .oo 1 .oo 
3 0.000 0.12 0.69 0.97 1 .oo 1 .oo 1 .oo 
of declaring linkage when there is no disease locus in the interval (A = 1.0) is no 
larger than 0.025 for the cases considered. This represents no more than eight false- 
positives, on average, in a genome scan of 300 markers. A more stringent lod score 
critical value, say k = 2, results in a false-positive rate of no more than .003 or an 
average of one false-positive in a genome scan of 300 markers, but at the expense of 
a considerable loss of power for detecting linkage when a locus lies in the interval. 
Using k = 1, a sample size of N = 400 ASPs provides 81% power to detect a disease 
locus with recurrence risk ratio h = 1.4; power is reduced to 49% or 23% for a 
critical value of 2 or 3. As always, the power to detect an effect of a given size is 
dependent on the sample size. A sample of N = 100 ASPs is sufficient to detect 
linkage of a locus with recurrence risk ratios h 2 3.0 with reasonable power for 
k = 1 or 2. N = 200-400 ASPs provide substantial power to detect a locus with 
h 2 1.6 for k = 1, and with N = 800 ASPs we may be able to detect a locus with 
h as small as 1.2. 
These results suggest that a reasonable strategy for a genome scan to localize a 
gene predisposing to a complex disease may be to screen the genome using a rel- 
atively low lod score critical value k ,  even as low as k = 1. A critical value of 
k = 1 gives excellent power at h L 1.4 for N 2 400 ASPs without resulting in a 
prohibitively large number of false-positives. While maximum lod scores as low as 
1 certainly should not be regarded as conclusive evidence for linkage, they can indi- 
cate intervals most likely to harbor disease loci and worthy of further investigation 
[see also Elston, 19921. 
Exclusion Mapping 
An advantage of our parametric ASP linkage method is that it allows exclusion 
of intervals for which there is substantial evidence against the presence of a disease 
locus conferring a specified recurrence risk ratio h~ [Risch, 19931. A reasonable strat- 
egy is to exclude those locations with lod(AE, 8, ;  0) 5 k ,  for some k < 0. Table VI 
130 Hauser et al. 
TABLE VI. Percentage of Intervals Excluding the True Disease Gene With Recurrence Risk 
Ratio A at Exclusion Recurrence Risk Ratios AE Using Lod 5 k as Exclusion Criterion* 










0.0 0.0 1.2 0.1 5.6 1.8 25.7 14.9 
0.0 0.0 0.3 0.1 3.7 1.2 25.2 18.1 
0.0 0.0 0.1 0.1 3.5 0.9 27.1 19.4 
0.0 0.0 0.2 0.0 3.5 1.2 29.5 21.4 
0.0 0.0 0.0 0.0 0.4 0.1 3.8 1.2 
0.0 0.0 0.0 0.0 0.3 0.0 1.7 0.6 
0.0 0.0 0.0 0.0 0.1 0.0 1.6 0.5 
0.0 0.0 0.0 0.0 0.1 0.1 1.6 0.7 
*N = 400 ASPs typed for markers with four equally-frequent alleles in a d cM intermarker distance, and 
disease locus in the middle of the interval. 
displays the probabilities of lod scores less than k = -1 or -2 at the location of 
a disease gene for which A = 1.6 or 2.0 when typing ASPs only. The percentages 
of falsely excluded intervals containing a disease locus with recurrence risk ratios 
A = 1.6 or 2.0 is comfortingly small for AE 5 A ,  even for the less stringent criti- 
cal value k = - 1. This suggests that this method will only rarely exclude an interval 
when that interval actually includes a disease locus with h 2 AE. However, since ex- 
cluding the disease locus is a very serious error, it may be preferable to use the more 
stringent critical value k = -2. 
Table VII shows the results for exclusion mapping when the interval does not 
contain a disease locus (A = 1.0) when we used as our exclusion criterion a lod score 
less than -2. As expected, as AE or N increases or d decreases, the percentage of 
each interval excluded and the probability that the entire interval is excluded both in- 
crease. For example, when typing N = 400 ASPs with an interval size of d = 20 cM, 
85% of the intervals were fully excluded for AE = 2.0, while less than 60% were 
fully excluded for AE = I .6. For AE = 1.6, the proportion of intervals fully excluded 
increased to 90% when d = 2 cM, suggesting that regions of the genome not com- 
pletely excluded in an initial genome scan may be excluded when more markers are 
typed in the region. 
Effect of Errors in Marker Map Parameters 
Population admixture can cause serious problems for linkage analysis methods 
in which identity by descent must be inferred from identity by state. To address this 
issue, we simulated markers with eight alleles of unequal frequencies (Table VIII) 
and constructed samples in which a fraction a of the ASPs came from a population 
with one set of allele frequencies and the remaining fraction 1 - a came from a 
population in which the frequencies of the most common allele and a second allele 
had been interchanged. 
For the case in which no disease locus was present (A = 1 .O), admixture resulted 
in a shift of the maximum lod score distribution toward larger values. Thus, for any 
critical value k ,  the false-positive rate was substantially increased. For example, the 
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TABLE VII. Average Percentage of the Interval Excluded (% Ex) and Percentage of Replicates 
for Which the Entire Interval Is Excluded (% All) When No Disease Locus Is Present (A = 1) 



















1.4 1.6 2.0 3 .O 
% E x  %All %Ex %All %Ex  %All %Ex %All 
3.1 0.1 5.3 2.8 20.8 12.6 55.2 44.5 
1.9 1.5 10.9 7.9 33.6 27.6 69.9 64.0 
2.7 2.4 16.4 14.3 42.0 38.3 77.0 73.7 
3.6 3.3 20.6 19.3 49.4 47.5 82.1 80.6 
7.0 3.6 29.4 20.7 58.8 48.8 87.7 81.4 
13.8 10.7 43.9 38.1 73.1 68.4 94.9 93.1 
18.3 16.1 52.4 49.0 80.7 78.5 96.4 95.5 
23.9 22.5 59.4 57.5 84.6 83.6 98.3 97.9 
32.9 24.2 69.0 59.4 90.3 85.4 98.9 97.8 
49.0 43.9 82.1 78.5 95.7 94.5 99.8 99.7 
56.3 53.1 87.1 85.1 97.2 96.7 99.9 99.9 
63.7 62.0 90.8 90.3 98.0 97.7 99.9 99.9 
70.8 61.4 93.9 90.7 99.2 98.5 100.0 100.0 
83.2 80.0 98.1 97.1 99.9 99.9 100.0 100.0 
88.3 86.6 98.9 98.7 99.9 99.9 100.0 100.0 
91.2 90.2 99.2 99.1 100.0 99.9 100.0 100.0 
false-positive rate increased from 0.026 without admixture to 0.132 given a = 20% 
admixture and allele frequency set B (see Table VIII) in the second population when 
we used critical value k = 1. 
This increase was initially rather alarming, since for a 300-marker genome scan 
it would suggest the need to follow up approximately 40 false-positives. However, 
when a disease locus is present (A > l .O) ,  admixture again results in a shift of the 
TABLE VIII. Effect of Population Admixture a on the Probability of a Maximum Lod Score 
Greater Than k When There Is No Disease Locus* 
a = 0.20 a = 0.50 
A k a = 0.00 A B A B 
1 .o 1 ,026 ,075 .132 ,139 ,257 
2 ,002 ,009 ,019 .025 ,063 
3 .ooo .002 ,004 ,005 ,012 
1.4 1 ,874 ,950 ,972 .977 ,989 
2 ,596 .795 ,879 .871 .944 
3 .3 14 .534 .676 .664 ,824 
2.0 1 1.000 1.000 1.000 1 .ow 1.000 
2 ,995 ,998 1.000 1.000 1.000 
3 ,976 .995 .999 ,997 1.000 
*N = 400, d = 10 cM distance between markers with eight alleles with frequencies 0.36,0.13,0.13,0.13, 
0.08, 0.08, 0.08, 0.01 and two sets of allele frequencies in an (a  : 1 - a )  admixed population. A: Allele 
frequencies in the second population are 0.13,0.36,0.13,0.13,0.08,0.08,0.08,0.01, respectively. B: Allele 
frequencies in the second population are 0.08,0.13,0.13,0.13,0.36,0.08,0.08,0.01, respectively. 
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maximum lod score distribution toward larger values and seems to do so in a way 
entirely parallel to that for the no linkage case. For example, k = 1 for the no admix- 
ture case and k = 2 for the case of a = 50% admixture and allele frequency set A 
result in similar false-positive rates (.026 and ,025, respectively). Using these same 
critical values also results in essentially identical power to detect linkage: 374  and 
371  when h = 1.4, and 1 .OOO and 1.000 when A = 2.0. Thus, by appropriate choice 
of the critical value k,  it appears to be possible to achieve the same false-positive rate 
without reducing power to detect linkage (see Discussion). 
Throughout we have assumed that the intermarker distance d is known without 
error. To test the effect of inaccurately specified d on linkage detection, we simulated 
data for d = 10 cM and then analyzed the data assuming various inflated or deflated 
values of d. We assumed a locus with risk h = 2.0 (ZO = 0.125), N = 400 ASPs, 
four equally frequent marker alleles, and disease locus in the middle of the interval. 
When d was assumed to be 5 cM, the expected maximum lod score decreased from 
6.12 to 4.86 and the average 20 increased from 0.129 to 0.145. When the intermarker 
distance was assumed to be 15 cM, the expected maximum lod score increased from 
6.12 to 6.57 and the average 20 decreased from 0.124 to 0.1 13. The average 21 was 
close to the true value of 5 cM, 4.7 and 4.9 for the 5 cM and 15 cM map, respectively. 
Apparently when the intermarker distance is incorrectly specified, the lod score and 
the estimate of the recurrence risk ratio reflect the underlying recombination fraction. 
For example, when the true intermarker distance is smaller than that specified in the 
analysis, there are fewer recombination events than expected, resulting in a higher 
lod score and an overestimate of the recurrence risk ratio. 
DISCUSSION 
The difficulties involved in the study of complex genetic disease by standard lod 
score methods have motivated several investigators to develop statistical techniques 
to map genes for such traits. Coupling ASP and affected-relative-pair methods for 
linkage analysis with recent advances in genotyping technology and the availability of 
dense genetic marker maps are currently active research areas. Several investigators 
have been and are pursuing methods similar to ours by using a standard linkage 
framework [Hyer et al., 19911 or a different parameterization of the disease model 
[Olson, 1995al. In addition, similar work has been done in the context of interval 
mapping of quantitative trait loci using relative pairs in experimental animals [Haley 
and Knott, 19921 and in humans [Goldgar, 1990; Fulker and Cardon, 1994; Olson, 
1995bl. A variety of genetic analysis techniques likely will be required to identify 
genetic components of common human diseases. 
Developing a Genome Screening Strategy 
Our results suggest that genotyping ASPs and no other family members with 
a map of genetic markers evenly spaced at 10- to 20-cM intervals provides an effi- 
cient strategy to map genes for complex genetic diseases when the limiting factor is 
the number of genotypes. Our simulations suggest that using a critical value of the 
lod score of k = 1 for linkage detection works well to identify intervals which may 
harbor a disease locus, while a critical value of k = -2 or even k = - 1 for linkage 
exclusion works well to identify regions that may be excluded from further consid- 
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eration for a gene with the specified marginal effect. Exclusion mapping provides a 
means for setting aside intervals which may not include a disease gene, saving ad- 
ditional typing efforts for those intervals which seem promising, or at least, provide 
little evidence against linkage. Using a lod score critical value of k = 1 for linkage 
detection minimizes the risk of missing a disease locus and results in investigation of 
a manageable number of type I errors. In a genome scan based on typing 300 mark- 
ers, we would expect about eight false-positives to be pursued. When a lod score 
greater than 1 is observed, the genomic region can be targeted for additional ge- 
netic studies. This investigation should include genotyping other available families 
or family members, genotyping additional markers in the intervals, and confirmatory 
analysis in independent samples. In addition, other genetic analysis methods can be 
employed. These might include linkage analysis with standard mode-of-inheritance 
based methods, combined linkage and segregation analysis, positional candidate gene 
studies, or disequilibrium mapping. 
We emphasize that a lod score greater than 1 for linkage detection is not meant 
to indicate conclusive or even strong evidence for linkage [Elston, 19921. Rather, we 
see this screening strategy as a means to prioritize genomic regions for further study. 
Intuitively, intervals with large positive lod scores should be investigated immediately, 
whereas areas with smaller positive lod scores may be investigated later. It also may 
be useful to develop a weighting scheme based on flanking marker heterozygosity 
when ordering intervals for further analyses. This strategy should provide an efficient 
strategy for rapid screening of the genome. It is important that any positive linkage 
results be confirmed in other samples of families when using this or any other linkage 
method for mapping a complex genetic trait. 
Modification of this strategy may be required in studying a particular complex 
disease. For diseases in which finding sufficient ASPs is difficult, typing additional 
nuclear family members can increase information for linkage, especially when one 
or both parents may be genotyped. In the absence of parental genotypes, genotyp- 
ing siblings in addition to the ASP provides more information for linkage than could 
be obtained from the ASP alone. In addition, it is useful to collect parents and ad- 
ditional siblings for subsequent genotyping to facilitate haplotype reconstruction and 
disequilibrium mapping once a disease gene is mapped. Finally, modifications in the 
lod score critical values may be required if families come from significantly admixed 
populations. 
Bias of Parameter Estimates 
The maximum likelihood estimates of the distance dl between the first flanking 
marker and the disease locus, and the probability that an ASP shares 0 genes identical 
by descent ZO, can be biased. In some cases this bias is forced by the fact that the 
true value of the parameter is on the boundary of the parameter space. For example, 
when there is no linked locus in the interval, zo = 0.25 and the estimate of zo must 
be 5 0.25. Similarly, when the disease locus is near a genetic marker, the estimate 
of dl is biased upward since we only considered positions within the interval in our 
analyses. The bias in the estimate of the disease locus position disappears when full 
multipoint mapping is used instead of interval mapping [Risch, 1990b; Fulker et al., 
19951. Risch [ 19931 has developed a full multipoint method of analysis for the case of 
typed parents [Risch, 1990b, 1993; Olson, 1995bl. We have extended this multipoint 
method to the case of untyped parents (unpublished results). 
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Sensitivity to Errors in the Marker Map 
Our method is robust to errors in the map distance between the flanking mark- 
ers, except when the errors are extreme. As with other relative pair methods when 
parents are not genotyped, our method can be sensitive to errors in allele frequen- 
cies. N = 200-800 ASPS provide sufficient information for reasonable estimates of 
allele frequencies by gene counting or maximum likelihood [Boehnke, 19911, and 
these estimates may then be used in the analysis. If the sample is known to be from 
an admixed population, the need to use a more stringent lod score criterion can be 
anticipated. The only difficulty in this strategy is in choosing the appropriate criti- 
cal value; in fact, it may be possible to do this empirically on the basis of numbers 
of positive results detected as a genome scan proceeds. In any event, intervals can 
be ranked by lod score, and intervals with the largest lod scores can be investigated 
first. As mentioned previously, taking into account marker polymorphism also may 
be useful in ranking intervals for further analysis. 
Distribution of the Maximum Lod Score 
The asymptotic distribution of our maximum lod score statistic is unknown be- 
cause of the nonidentifiability of 8, (or d , )  when z = [ 1 /4,1/2,1/4], or for additive 
models when A = 1.0. The asymptotic distribution of the usual lod score statistic 
multiplied by 21n 10 is a 5050 mixture of a point mass at 0 and a x2 on one de- 
gree of freedom. As expected, our empirical probabilities were somewhat larger than 
those predicted by this mixture distribution since we are maximizing over one (A)  or 
two (zo and z l )  additional parameters. For a given data set and genotyped flanking 
markers, empirical power and size estimates can easily be determined by simulating 
several thousand replicate data sets under the null hypothesis of linkage (A > 1 .O) or 
no linkage (A = 1.0). 
Applying the Method to Genetic Models That Are Not Additive 
Many genetic models of interest are not additive. For many complex genetic 
diseases, there exists little evidence of a large dominance variance or, for our pur- 
poses, a large difference in recurrence risks to sibs compared to recurrence risks to 
offspring, especially for small A values [Risch, 1990~1. While we have used addi- 
tivity as a simplifying assumption in most of our simulations, our recurrence risk 
ratio linkage method does not require this assumption. Because without the additiv- 
ity assumption we use two parameters rather than one, increased critical values will 
be required to maintain the same rate of false-positive linkage detection. When A is 
small there may be little power to detect departures from additivity. We currently are 
examining the relative merits of genome screening with and without the additivity 
assumption. 
Multi-Locus Disease Models 
In this work we have assumed that the marginal effect of a given disease locus 
can be detected, even in the presence of other genes for the disease. The ability of 
our method to detect marginal effects of disease genes caused by multi-locus dis- 
ease model is dependent on the distortion of the ASP IBD distribution from z = 
[1/4,1/2,1/4] at each locus. It may be that diseases exist for which the distortion 
of the marginal ASP IBD distribution is not detectable but that the distortion in the 
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ASP IBD distribution is detectable for combinations of loci. In that case, a genome 
scan may not identify single intervals as important in disease etiology, and two or 
more intervals will have to be examined simultaneously. We plan to examine the 
impact of multiple interacting loci on the genome screening strategy described above. 
Extension of our method to multiple disease loci is possible at the cost of substantially 
increased computation. 
Extensions to Multiple Affected Family Members 
In our method as we have described it, only the disease phenotypes of the ASP 
are used; disease status of other family members is ignored. When there are more 
than two affected siblings in a family or two or more ASPs in a pedigree, we can 
construct all possible ASPs and analyze the sib pairs and if desired, the complete 
nuclear families, as if they were independent. This violation of the assumption of 
the independence of the ASPs may result in a maximum lod score distribution with 
heavier tails than the distribution with the same number of independent ASPs, intro- 
ducing an anti-conservative bias in the P values. When positive linkage results are 
obtained, an additional simulation step should be included to estimate the empirical 
P value when some of the ASPs are from the same sibships or pedigrees. 
Incorporating disease status information on other relatives of the ASP is more 
complicated. To do so efficiently requires that we assume knowledge of a particular 
genetic model in order to identify the expected IBD sharing distribution among the 
set of affected relatives. This is a difficult problem and depends on the pedigree 
structure. As an intermediate step to incorporating disease phenotype on all family 
members we could stratify by parental disease phenotype. Risch (unpublished data) 
examined power for families including zero, one, or two affected parents and up to 
three affected siblings and found that pairs with two affected parents generally have 
lower power than pairs with zero or one affected parents for most genetic models 
examined. Sibships with zero or one affected parents exhibited similar deviations in 
IBD sharing and similar power to detect linkage. When ASPs are plentiful, it may be 
more efficient to pool sibships with zero to one affected parents, and avoid sibships 
with two affected parents. We plan to examine the effect of incorporating the disease 
phenotypes of additional nuclear family members, including stratifying families by 
parental disease phenotype. 
CONCLUSIONS 
This extension of Risch’s likelihood-based mode-of-inheritance-free method of 
interval mapping for complex genetic diseases to use information from relatives to in- 
fer IBD status of the ASP is computationally efficient and flexible. It makes efficient 
use of additional siblings to increase information about marker and hence disease 
locus IBD status in the ASP, and it allows for disease gene localization and exclu- 
sion. The underlying genetic model based on the recurrence risk ratio is simple, and 
the parameter(s) are easily interpreted. New methods of automated genotyping can 
provide a first-pass genome scan of large numbers of families very rapidly. This sta- 
tistical method allows for efficient analysis of those data. The FORTRAN computer 
package SIBLINK, for linkage detection, exclusion mapping, and estimation of P 
values, is available from the authors free of charge. 
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